CYP19A1 and prostate cancer: The normal prostate expresses aromatase that converts androgen to estrogen within the stroma but during malignancy, expression is increased in prostate cancer cells and thus, can lead to enhanced biosynthesis of estrogens in the local environment of the prostate [3].